Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Singh & Associates ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4  
>>Next
 
Title
Country
Organisation
Author
Date
1
FDA Approves Balversa, A First Targeted Therapy For Metastatic Bladder Cancer
On April 12, 2019, the USFDA granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration ...
United States
20 May 2019
2
ICMR Licenses Shigella Vaccine Technology To Hilleman Laboratories
On April 23, 2019, Indian Council of Medical Research (ICMR) licensed the technology for Shigella vaccine for further scaling up and commercialisation to MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
India
17 May 2019
3
European Commission Approval To Rituximab Is First Biologic Treatment For A Rare Autoimmune Disease
These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
European Union
17 Apr 2019
4
USFDA Approves First And Only Treatment For A Type Of Inflammatory Arthritis
This is the first and only treatment for nraxSpA approved by USFDA.
India
17 Apr 2019
5
Government Proposes Second Draft Amendment Of Clinical Establishment Rules, 2019
Reported draft notification on revised Rules is based on recommendations of a panel set up by the ministry on August 04, 2018.
India
16 Apr 2019
6
EMA Publishes New Guidelines For Certain Medical Devices
On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
European Union
19 Mar 2019
7
Centre Has Drafted The First Regulatory Guidelines For Evaluation Of Nano-Pharmaceuticals In India
In February 2019, the Government of India introduced first draft regulatory guidelines for evaluation of nanopharmaceutical products for therapeutic use in the country.
India
19 Mar 2019
8
Cosmetics Manufacturers May Submit Product Composition Details Before Licensing Their Products
Central Government, in order to enhance the safety of the cosmetic products, has proposed the product composition details clause shall be mentioned in the approval issued by the licensing authority in the country.
India
19 Mar 2019
9
DoP Proposes Mandatory Quality Control Orders (QCOs) For Certain Medical Devices
On February 15, 2019, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers issued six draft QCOs, after consulting with the Bureau of Indian Standards to ensure safety and effectiveness of these medical devices:
India
18 Mar 2019
10
Central Government Notifies All Implantable Devices As Drugs
On February 08, 2019, the Central Government announced that all Implantable Medical Devices along with CT scan Equipment, MRI Equipment, Defibrillators, Dialysis Machine, PET Equipment, X-Ray Machine, and ...
India
18 Mar 2019
11
Delhi HC Quashes Ban On Wockhardt's Anti-Inflammatory Drug
The Delhi High Court, on January 01, 2019, set aside the Central Government's ban on Wockhardt's anti-inflammatory medicine ‘Ace Proxyvon', a Fixed Dose combination of Aceclofenac 100 mg, Paracetamol 325 mg ...
India
21 Feb 2019
12
Government Constitutes NITI-led Committee To Monitor Pricing Of Drugs
The Central Government, with an aim to offer medicines/healthcare products at affordable prices to the public, has taken a number of measures ranging from making drugs available through Jan Aushadhi stores ...
India
20 Feb 2019
13
The DNA Technology (Use And Application) Regulation Bill 2019
In a landmark decision, the Lok Sabha, on January 08, 2019, passed the "DNA Technology (Use and Application) Regulation Bill - 20193" (here after referred as "Bill").
India
20 Feb 2019
14
Patent Licensing
A patent is a right granted to the owner to stop others from using his invention without his consent for making, using, selling or offering for sale his patent.
India
21 Dec 2018
15
FDA Approval To Larotrectinib Is The First Treatment To Receive A Tumor-Agnostic Indication
Larotrectinib, is a CNS active TRK inhibitor designed to inhibit these proteins.
Worldwide
13 Dec 2018
17
NPPA Updates For The Month Of November 2018
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
India
12 Dec 2018
18
India's Tryst With "Evergreening" – An Ongoing Battle.
Evergreening is the term used for legal and technological alternatives adopted by Pharmaceutical companies to extend their exclusivity of over production and sale of patented medicines...
India
7 Dec 2018
19
Biotechnology Patent And Related Moral Issues
Biotechnology inventions are important for human development. It is the broad area of biology involving living systems and organisms to develop or make products, or any technological application ...
India
26 Nov 2018
20
After Banning Manufacturing, Sale And Distribution Of Antibody Detecting Rapid Diagnostic Tests For The Diagnosis Of Malaria, The Health Ministry Now Bans Its Import Too
On October 30, 2018, the Ministry of Health and Family Welfare (MoHFW) banned the import of Antibody Detecting Rapid Diagnostic Tests (ADRDTs) used for routine diagnosis of Malaria.
India
22 Nov 2018
Links to Result pages
 
1 2 3 4  
>>Next